Dr. Mark P. Ombrellaro, MD

Dr. Ombrellaro practices at Fairbanks Memorial Hospital in Fairbanks, Alaska, part of Fairbanks Hospital Foundation.

Dr. Ombrellaro's NPI, 1699793968, was assigned on July 17, 2006. Dr. Ombrellaro graduated from University Of Washington School Of Medicine in 1987. Dr. Ombrellaro's Washington license number on file is MD00033502.

Dr. Ombrellaro's primary practice is Fairbanks Memorial Hospital, at 1650 Cowles Street, Fairbanks, AK 99701 in Fairbanks North Star Borough. The practice phone is (907) 452-8181.

Dr. Ombrellaro's primary practice is Fairbanks Memorial Hospital in Fairbanks, Alaska, part of Fairbanks Hospital Foundation. The medical group on file is Porter Heart & Vascular Center. Dmand AI also links Dr. Ombrellaro to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ombrellaro practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Ombrellaro's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Ombrellaro is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Ombrellaro's licenses on file in 9 states: Washington, Alaska, Colorado, Michigan, Montana, Wyoming, Tennessee, Oklahoma and Texas.

Dmand AI lists amputation, chronic skin ulcer, leg revascularization and peripheral vascular disease among the conditions Dr. Ombrellaro treats.

CMS data shows 1,702 Medicare services from Dr. Ombrellaro across 24 procedure codes in 2024, for 496 Medicare patients. Medicare paid $158,391 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 496 Medicare patients who saw Dr. Ombrellaro in 2024. The largest group is 65 to 74, with 229 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ombrellaro's median patient age at 66, with 48% women.

In 2022, Dr. Ombrellaro wrote 16 Medicare Part D claims. They cover 1 drug, with $254 in total drug cost. In 2021, CMS named 43 claims across 2 drugs.

Dr. Ombrellaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of leg revascularization (restoring blood flow) by Dr. Ombrellaro, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Ombrellaro. The most frequent topics are Aorta, Abdominal, Dogs and Stents. Dr. Ombrellaro has published most often in Am J Surg. Dr. Ombrellaro's most frequent co-authors are Mitchell H. Goldman, MD, Michael Benton Freeman, MD and Michael Brandon Freeman, MD.

CMS Open Payments shows 360 general payments to Dr. Ombrellaro from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. The Spectranetics Corporation paid the most, $22,140.

Dmand AI lists 3 awards for Dr. Ombrellaro, most recently ACS Fellow in 2012.

Dr. Ombrellaro graduated from University Of Washington School Of Medicine in 1987. Dr. Ombrellaro is a member of ACS.

Dr. Ombrellaro is in network with 8 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.